
Shineco, Inc. TYHT
Shineco, Inc. DPO | TYHT
DPO Jährlich Shineco, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 3.08 | 3.61 | 28.5 | 2.52 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 28.5 | 2.52 | 9.42 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Zealand Pharma A/S
ZEAL
|
66.1 | - | 0.52 % | $ 821 M | ||
|
Zogenix, Inc.
ZGNX
|
8.04 K | - | -4.97 % | $ 664 M | ||
|
Xenon Pharmaceuticals
XENE
|
40.5 | $ 41.4 | 2.35 % | $ 3.28 B | ||
|
ADMA Biologics
ADMA
|
35.9 | $ 12.67 | -0.98 % | $ 3.02 B | ||
|
Daré Bioscience
DARE
|
1.64 K | $ 0.69 | 1.75 % | $ 7.71 M | ||
|
Halozyme Therapeutics
HALO
|
24.8 | $ 103.0 | 0.08 % | $ 12.3 B | ||
|
Hutchison China MediTech Limited
HCM
|
47.8 | $ 15.34 | 0.1 % | $ 13.2 B | ||
|
Aptorum Group Limited
APM
|
2.67 K | - | - | $ 5.72 M | ||
|
iBio
IBIO
|
5.51 K | $ 0.78 | -1.89 % | $ 81.2 M | ||
|
Karyopharm Therapeutics
KPTI
|
149 | $ 0.02 | -54.5 % | $ 219 | ||
|
Catalyst Pharmaceuticals
CPRX
|
58.1 | - | - | $ 3.85 B | ||
|
UroGen Pharma Ltd.
URGN
|
338 | $ 25.32 | -3.78 % | $ 1.22 B | ||
|
Catalyst Biosciences
CBIO
|
7.82 | $ 13.91 | 1.9 % | $ 1.24 B | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
ADiTx Therapeutics
ADTX
|
1.09 M | - | - | $ 374 | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
5.24 K | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
BeiGene, Ltd.
BGNE
|
355 | - | 0.49 % | $ 251 B | ||
|
EyePoint Pharmaceuticals
EYPT
|
302 | $ 0.39 | 9.06 % | $ 28.6 K | ||
|
ChromaDex Corporation
CDXC
|
76.3 | - | -0.88 % | $ 598 M | ||
|
Caladrius Biosciences
CLBS
|
51.2 | - | -16.75 % | $ 25.8 M |